5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
    23.
    发明授权
    5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones 失效
    5,8-二氢-6H-吡啶并[2,3-d]嘧啶-7-酮

    公开(公告)号:US07098332B2

    公开(公告)日:2006-08-29

    申请号:US10731594

    申请日:2003-12-08

    IPC分类号: C07D471/04 A61K31/519

    CPC分类号: C07D471/04

    摘要: The invention provides 5,8-dihydro-6H-pyrido[2,3-d]pyrimidin-7-one compounds that are selective inhibitors of KDR and FGFR kinases, and are useful in the treatment of cancers. The compounds have the generic structure I where Ar, Ar′, and R1 are as set forth in the present specification. The invention also provides pharmaceutical compositions containing these compounds and methods for their use.

    摘要翻译: 本发明提供作为KDR和FGFR激酶的选择性抑制剂的5,8-二氢-6H-吡啶并[2,3-d]嘧啶-7-酮化合物,并且可用于治疗癌症。 化合物具有通式结构I,其中Ar,Ar'和R 1如本说明书所述。 本发明还提供含有这些化合物的药物组合物及其使用方法。

    4,5-pyrazinoxindoles
    24.
    发明授权
    4,5-pyrazinoxindoles 失效
    4,5 - 吡嗪并吲哚

    公开(公告)号:US06221867B1

    公开(公告)日:2001-04-24

    申请号:US09464534

    申请日:1999-12-15

    IPC分类号: C07D24136

    CPC分类号: C07D487/04

    摘要: Disclosed are novel 4,5-pyrazinoxindoles having the formula These compounds inhibit or modulate protein kinases, in particular JNK protein kinases. These compounds and their pharmaceutically acceptable salts, and prodrugs of said compounds, are useful as anti-inflammatory agents, particularly useful in the treatment of rheumatoid arthritis. Also disclosed are pharmaceutical compositions containing such compounds, and methods for the treatment and/or control of inflammation, particularly in the treatment or control of rheumatoid arthritis, using these compounds.

    摘要翻译: 公开了具有下式的新的4,5-吡嗪氧吲哚:这些化合物抑制或调节蛋白激酶,特别是JNK蛋白激酶。 这些化合物及其药学上可接受的盐和所述化合物的前药可用作抗炎剂,特别可用于治疗类风湿性关节炎。 还公开了含有这些化合物的药物组合物,以及使用这些化合物治疗和/或控制炎症,特别是治疗或控制类风湿性关节炎的方法。

    1-thiaguanosine and process for preparing oxanosine and 1-thiaguanosine
    25.
    发明授权
    1-thiaguanosine and process for preparing oxanosine and 1-thiaguanosine 失效
    1-thiaguanosine和制备oxososine和1-thiaguanosine的方法

    公开(公告)号:US5243042A

    公开(公告)日:1993-09-07

    申请号:US561628

    申请日:1990-08-02

    IPC分类号: C07H19/24

    CPC分类号: C07H19/24

    摘要: The invention relates to antibacterially active 5-amino-3-(.beta.-D-ribofuranosyl)imidazo[4,5-d][1,3]thiazin-7(3H)-one, also referred to as 1-thiaguanosine, a composition and method comprising the same and processes and intermediates for the preparation of 1-thiaguanosine and 5-amino-3-(.beta.-D-ribofuranosyl)imidazo[4,5-d][1,3]oxazin-7(3H)-one, also referred to as oxanosine, a known compound.

    摘要翻译: 本发明涉及抗菌活性的5-氨基-3-(β-D-呋喃核糖基)咪唑并[4,5-d] [1,3]噻嗪-7(3H) - 酮,也称为1-噻二胍,a 包括其组成和方法,以及用于制备1-硫杂鸟嘌呤和5-氨基-3-(β-D-呋喃核糖基)咪唑并[4,5-d] [1,3]恶嗪-7(3H) - 酮的方法和中间体。 - 一种,也称为二恶烷,已知化合物。

    1,6- AND 1,8-NAPHTHYRIDINES
    26.
    发明申请
    1,6- AND 1,8-NAPHTHYRIDINES 审中-公开
    1,6-和1,8-萘啶

    公开(公告)号:US20120184562A1

    公开(公告)日:2012-07-19

    申请号:US13348668

    申请日:2012-01-12

    申请人: Kin-Chun Luk

    发明人: Kin-Chun Luk

    CPC分类号: C07D471/04

    摘要: Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer, Down syndrome or early onset Alzheimer's disease.

    摘要翻译: 本发明描述了式及其药学上可接受的盐的化合物,以及含有所述化合物及其药学上可接受的盐的药物组合物,以及所述化合物和药物组合物用于治疗,控制或改善增殖性疾病(包括癌症)Down 综合征或早发性阿尔茨海默氏病。